4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-23-057220
President and CEO acquired 2,284 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Domzalski David · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-30 | Grant or award : show line 1 in the form | +2,284 | $2.81 | $6,426 | 46,168 | D |
Loading xslF345X05/doc4.xml…